Irland -
engelska -
HPRA (Health Products Regulatory Authority)
foznol 1000 mg chewable tablets
shire pharmaceuticals ireland limited - lanthanum carbonate hydrate - chewable tablet - 1000 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; lanthanum carbonate
Irland -
engelska -
HPRA (Health Products Regulatory Authority)
foznol 250 mg chewable tablets
shire pharmaceuticals ireland limited - lanthanum carbonate hydrate - chewable tablet - 250 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; lanthanum carbonate
Irland -
engelska -
HPRA (Health Products Regulatory Authority)
foznol 500 mg chewable tablets
shire pharmaceuticals ireland limited - lanthanum carbonate hydrate - chewable tablet - 500 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; lanthanum carbonate
Irland -
engelska -
HPRA (Health Products Regulatory Authority)
foznol 750 mg chewable tablets
shire pharmaceuticals ireland limited - lanthanum carbonate hydrate - chewable tablet - 750 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; lanthanum carbonate
Irland -
engelska -
HPRA (Health Products Regulatory Authority)
foznol 750 milligram oral powder
shire pharmaceutical contracts ltd - lanthanum carbonate hydrate - oral powder - 750 milligram - drugs for treatment of hyperkalemia and hyperphosphatemia
Irland -
engelska -
HPRA (Health Products Regulatory Authority)
foznol 1000 milligram oral powder
shire pharmaceutical contracts ltd - lanthanum carbonate hydrate - oral powder - 1000 milligram - drugs for treatment of hyperkalemia and hyperphosphatemia
Irland -
engelska -
HPRA (Health Products Regulatory Authority)
mezavant xl 1200 mg gastro-resistant, prolonged release tablets
shire pharmaceuticals ireland limited - mesalazine - prolonged-release tablet - 1200 milligram(s) - aminosalicylic acid and similar agents; mesalazine
Malta -
engelska -
Medicines Authority
foznol 750mg oral powder
shire pharmaceuticals ireland limited block 2 & 3 miesian plaza, 50-58 baggot street lower, dublin 2, ireland - lanthanum - oral powder - lanthanum 750 mg - all other therapeutic products
Storbritannien -
engelska -
MHRA (Medicines & Healthcare Products Regulatory Agency)
xagrid 500microgram capsules
shire pharmaceuticals ltd - anagrelide hydrochloride - capsule - 500microgram
Israel -
engelska -
Ministry of Health
vyvanse 30 mg
medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 30 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established